Developing a standard approach to immune checkpoint inhibitor toxicity management in Ontario.

被引：0
|
作者：
Crespo, Andrea
Abella, Lourdes
Baetz, Tara D.
Gallo-Hershberg, Daniela
Lakhani, Nita
Leighl, Natasha B.
Pasetka, Mark
Seymour, Lesley
Vu, Kathy
Forbes, Leta Marie
机构：
[1] Canc Care Ontario, Toronto, ON, Canada
[2] Canc Ctr Southeastern Ontario, Kingston, ON, Canada
[3] Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 30期
关键词：
D O I：
10.1200/JCO.2018.36.30_suppl.255
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
255
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Biomarkers of immune checkpoint inhibitor response and toxicity: Challenges and opportunities
    Goodman, Rachel S.
    Jung, Seungyeon
    Balko, Justin M.
    Johnson, Douglas B.
    IMMUNOLOGICAL REVIEWS, 2023, 318 (01) : 157 - 166
  • [32] The Role of Aging and Senescence in Immune Checkpoint Inhibitor Response and Toxicity
    Jain, Sidharth S.
    Burton Sojo, Giselle
    Sun, Harry
    Friedland, Benjamin N.
    Mcnamara, Megan E.
    Schmidt, Marcel O.
    Wellstein, Anton
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [33] Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines
    Kang, Jee Hye
    Bluestone, Jeffrey A.
    Young, Arabella
    TRENDS IN IMMUNOLOGY, 2021, 42 (04) : 293 - 311
  • [34] Immune checkpoint inhibitor toxicity in the clinical practice setting.
    Schmidt, Laura
    McGuire, Brian
    Hui, Wendy
    Carro, George W.
    Hensing, Thomas A.
    Shevrin, Daniel H.
    Campbell, Nicholas Paul
    Hanson, Britt Erika
    Brockstein, Bruce
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] Concomitant Medication Effects on Immune Checkpoint Inhibitor Efficacy and Toxicity
    Sieber, Brendan
    Strauss, Julius
    Li, Zihai
    Gatti-Mays, Margaret E.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [36] A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis
    Valente, Monica
    Colucci, Maura
    Vegni, Virginia
    Croce, Valentina
    Bellan, Cristiana
    Rossi, Giulia
    Gibilisco, Giulia
    Frongia, Francesco
    Guazzo, Raffaella
    Ghiribelli, Claudia
    Bargagli, Elena
    Savelli, Vinno
    Ravara, Matteo
    Sani, Tommaso
    Simonetti, Elena
    Maio, Michele
    Calabro, Luana
    Di Giacomo, Anna Maria
    ONCOTARGETS AND THERAPY, 2024, 17 : 673 - 681
  • [37] Toxicity management in patients treated with immune checkpoint inhibitors
    Rothschild, S., I
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 147 - 148
  • [38] Management of pulmonary toxicity associated with immune checkpoint inhibitors
    Delaunay, Myriam
    Prevot, Gregoire
    Collot, Samia
    Guilleminault, Laurent
    Didier, Alain
    Mazieres, Julien
    EUROPEAN RESPIRATORY REVIEW, 2019, 28 (154):
  • [39] Using a disease pathway management approach to improve the quality of breast cancer care in Ontario.
    Eisen, Andrea
    Soobrian, Jasmin
    Tyrrell, Ashley
    Li, Clement
    Muradali, Derek
    Forbes, Margaret F.
    Gollnow, Angelika
    Ross, Jillian
    Holloway, Claire
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [40] Immune Checkpoint Inhibitor Pneumonitis: Heterogeneity in Clinical Management
    Filsoof, D.
    Padda, S. K.
    Garcia, P.
    Stedman, M.
    Neal, J. W.
    Wakelee, H. A.
    Ramchandran, K.
    Das, M.
    Ramsey, M.
    Bedi, H. S.
    Sung, A.
    Raj, R.
    Anand, S.
    de Boer, K.
    Katsumoto, T. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345